Skip to main content
OpenTrials

Clinical trial condition

Histiocytic Disorders, Malignant

Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.

260 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Histiocytic Disorders, Malignant trial results

Completed

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01231919

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

NCT00002485

Conditions
Adnexal Diseases, Astrocytoma, Brain Diseases, +96 more
Locations
  • University of California Davis Medical Center Sacramento, California, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • CCOP - Florida Pediatric Tampa, Florida, United States
View all 31 locations
View Trial Details
Completed

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

NCT00066248

Conditions
Astrocytoma, Blast Crisis, Body Weight, +83 more
Locations
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
View all 43 locations
View Trial Details
Completed

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

NCT01273090

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +58 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Completed

Quality of Life in Children Treated for Cancer

NCT00005881

Conditions
Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +27 more
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
View all 17 locations
View Trial Details
Completed

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

NCT00006340

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +47 more
Locations
  • Methodist Cancer Center at Methodist Hospital Indianapolis, Indiana, United States
  • Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Hopital Necker Paris, France
View Trial Details

Related conditions